Allied Market Research published a report, titled, "Cytogenetics Market by Product (Consumable, Instrument, Software and Service), by Technique (Comparative Genome Hybridization, Fluorescence in Situ ...

Molecular Instruments® (MI), founded by the inventor of the HCR™ technology, today announces the launch of the HCR™ Gold and ...

The technology, FISH-scRACS-seq (Fluorescence In Situ Hybridization-guided Single-Cell Raman-activated Sorting and Sequencing), utilizes a Raman-activated optical tweezers-based cell sorter ...

Unlike techniques like FISH (Fluorescence In Situ Hybridization) that target specific regions, CGH offers a genome-wide analysis. This allows researchers to identify copy number variations (CNVs ...

Molecular Instruments® (MI), founded by the inventor of the HCR technology, today announces the launch of the HCR Gold and HCR Pro product lines. These offerings significantly expand the HCR imaging ...

in order to investigate the efficacy and tolerance of trastuzumab in combination with paclitaxel and carboplatin in patients with HER2-positive (fluorescence in situ hybridization [FISH] positive ...

Patient characteristics collected at diagnosis included age, sex, International Staging System stage, revised International Staging System stage, and interphase fluorescence in situ hybridization ...

In a report released today, Matt Hewitt from Craig-Hallum assigned a Buy rating to NeoGenomics (NEO – Research Report). The company’s shares ...

The PATHWAY HER2 (4B5) test, the first and only FDA approved companion diagnostic for assessing HER2-low status since 2022, ...